1379 related articles for article (PubMed ID: 18043095)
1. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
2. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of moderately steatotic donor liver in transplantation.
Gao F; Xu X; Ling Q; Wu J; Zhou L; Xie HY; Wang HP; Zheng SS
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):29-33. PubMed ID: 19208511
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term outcomes after steatotic liver transplantation.
Doyle MB; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Brunt EM; Chapman WC
Arch Surg; 2010 Jul; 145(7):653-60. PubMed ID: 20644128
[TBL] [Abstract][Full Text] [Related]
6. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
7. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
8. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
[TBL] [Abstract][Full Text] [Related]
9. Reversal of graft steatosis after liver transplantation: prospective study.
Li J; Liu B; Yan LN; Zuo YX; Li B; Zeng Y; Zhang SF; Li FG
Transplant Proc; 2009 Nov; 41(9):3560-3. PubMed ID: 19917344
[TBL] [Abstract][Full Text] [Related]
10. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
11. Effect of graft steatosis on liver function and organ survival after liver transplantation.
Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
[TBL] [Abstract][Full Text] [Related]
12. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
[TBL] [Abstract][Full Text] [Related]
13. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
14. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
[TBL] [Abstract][Full Text] [Related]
15. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
Gastaca M
Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
[TBL] [Abstract][Full Text] [Related]
16. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
18. Using elderly donors in liver transplantation.
Grazi GL; Ravaioli M; Zanello M; Ercolani G; Cescon M; Varotti G; Del Gaudio M; Vetrone G; Lauro A; Ramacciato G; Pinna AD
Transplant Proc; 2005; 37(6):2582-3. PubMed ID: 16182750
[TBL] [Abstract][Full Text] [Related]
19. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
[TBL] [Abstract][Full Text] [Related]
20. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
